Nitric oxide/cGMP-mediated effects in the outflow region of the lower urinary tract—is there a basis for pharmacological targeting of cGMP? Petter Hedlund Topic Paper 08 November 2005 Pages: 362 - 367
Distribution and functional significance of phosphodiesterase isoenzymes in the human lower urinary tract Stefan ÜckertChristian G. StiefPetter Hedlund Topic Paper 06 December 2005 Pages: 368 - 373
Clinical update on phosphodiesterase type-5 inhibitors for erectile dysfunction Alberto BrigantiAndrea SaloniaFrancesco Montorsi Topic Paper 05 November 2005 Pages: 374 - 384
Treating erectile dysfunction by endothelial rehabilitation with phosphodiesterase 5 inhibitors Frank SommerWolfgang Schulze Topic Paper 05 November 2005 Pages: 385 - 392
Phosphodiesterase inhibitors in female sexual dysfunction Margit MayerChristian G. StiefStefan Ückert Topic Paper 25 October 2005 Pages: 393 - 397
In vitro functional responses of isolated human vaginal tissue to selective phosphodiesterase inhibitors Stefan ÜckertVicky EhlersUdo Jonas Topic Paper 05 November 2005 Pages: 398 - 404
Cyclic AMP-specific and cyclic GMP-specific phosphodiesterase isoenzymes in human cavernous arteries—immunohistochemical distribution and functional significance Eginhard WaldkirchStefan ÜckertPetter Hedlund Topic Paper 15 November 2005 Pages: 405 - 410
Fascicular anatomy and surgical access of the human pudendal nerve Kenneth J. GustafsonPaul F. ZelkovicWarren M. Grill Original Article 07 December 2005 Pages: 411 - 418
Follow-up of men obtaining a six-core versus a ten-core benign prostate biopsy 7 years previously Clemens BrossnerStefan MadersbacherMichael Rauchenwald Original Article 03 December 2005 Pages: 419 - 421
Sexual activity, sexual dysfunction and associated help-seeking behaviours in middle-aged and older adults in Spain: a population survey Edson D. Moreira Jr.Dale B. GlasserOn behalf of The GSSAB Investigators’ Group Original Article 08 December 2005 Pages: 422 - 429